Kurz Michael | Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
スポンサーリンク
概要
関連著者
-
Kurz Michael
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz M
Aventis Pharma Frankfurt Am Main Deu
-
Knauf M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Vertesy Laszlo
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Wink Joachim
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Seibert G.
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Vogel Martin
Aventis Pharma Deutschland Gmbh Global Preclinical Development Analytics
-
Kurz Michael
Aventis Pharma
-
VOGEL Martin
Hoechst Marion Roussel Deutschland GmbH
-
Schiell Matthias
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Schummer Dietmar
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Aretz W
Aventis Pharma Deutschland Gmbh Frankfurt Am Main Deu
-
VERTESY Laszlo
Hoechst Marion Roussel Deutschland GmbH
-
ARETZ Werner
Hoechst Marion Roussel Deutschland GmbH
-
EHLERS Eberhard
Hoechst Marion Roussel Deutschland GmbH
-
KURZ Michael
Hoechst Marion Roussel Deutschland GmbH
-
WINK Joachim
Hoechst Marion Roussel Deutschland GmbH
-
Kurz Michael
Hoechst Marion Roussel Core Research Functions
-
SCHUMMER DIETMAR
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
SEIBERT Gerhard
Aventis Pharma Deutschland GmbH, Division Lead Generation
-
Ferrari P
Marion Merrell Dow Research Institute Lepetit Research Center
-
Ferrari P
Marion Merrell Dow Res. Inst. Gerenzano (va) Ita
-
Ferrari P
Biosearch Italia S.p.a. Gerenzano (va) Ita
-
Ferrari Pietro
Biosearch Italia S. P. A.
-
Ferrari Pietro
Lepetit Research Center
-
Goldstein B
Biosearch Italia S. P. A.
-
MARKUS Astrid
Hoechst Marion Roussel Deutschland GmbH
-
SCHIELL Matthias
Hoechst Marion Roussel Deutschland GmbH
-
KOGLER Herbert
Hoechst Marion Roussel Deutschland GmbH
-
KNAUF Martin
Hoechst Marion Roussel Deutschland GmbH. Drug Innovation & Approval.
-
Kurz Michael
Marion Merrell Dow Research Institute Lepetit Research Center
-
Paulus E.f.
Institut Fur Mineralogie/kristallographie Der Johann Wolfgang Goethe-universitat
-
Kogler H
Aventis Pharma Deutschland Gmbh
-
Ehrlich Klaus
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Knauf Martin
Hoechst Marion Roussel Deutschland Gmbh Drug Innovation & Approval Natural Product Research
-
Isert D
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Markus Astrid
Aventis Pharma Deutschland Gmbh
-
Bonnefoy Alain
Dg Antiinfectives
-
TOTI LUIGI
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
VERTESY Laszlo
LG Natural Product Research
-
Toti Luigi
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Segeth Marian
Aventis Pharma Deutschiand Gmbh Drug Innovation & Approval
-
FERRARI Pietro
Marion Merrell Dow Research Institute, Lepetit Research Center
-
GOLDSTEIN Beth
Marion Merrell Dow Research Institute, Lepetit Research Center
-
DENARO Maurizio
Marion Merrell Dow Research Institute, Lepetit Research Center
-
Stefanelli S
Ipia G. Galilei
-
Denaro M
Lepetit Res. Center Gerenzano (va) Ita
-
COLOMBO Luigi
Si Technology Development, Texas Instruments Inc.
-
Hammann P
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Hammann Peter
Hoechst Marion Roussel Deutschland Gmbh
-
BONNEFOY Alain
Hoechst Marion Roussel France
-
HAWSER Stephen
Hoechst Marion Roussel
-
ISERT Dieter
Hoechst Marion Roussel Core Research Functions
-
SELVA ENRICO
Vicuron Pharmaceuticals via R. Lepetit
-
Corti Emiliana
Vicuron Pharmaceuticals
-
Ciabatti R
Bioseach
-
Selva E
Vicuron Pharmaceuticals S.r.l
-
Malabarba A
Bioseach
-
Colombo Luigi
Si Technology Development Texas Instruments Inc.
-
Hawser S
Hoechst Marion Roussel Romainville Fra
-
SEGETH MARIAN
Aventis Pharma Deutschiand GmbH, Drug Innovation & Approval
-
BRONSTRUE MARK
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
KNAUF MARTIN
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
WETZEL-RAYNAI MARIE-CELILE
DG Antiinfectives
-
SEIBER GERHARD
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BARBONE Francis
Aventis Pharmaceuticals Inc.
-
CASHMEN Elizabeth
Aventis Pharmaceuticals Inc.
-
DECKER Heinrich
Aventis Pharma Deutschland GmbH
-
EHRLICH Klaus
Drug Innovation & Approval
-
JORDAN Birgit
Drug Innovation & Approval
-
KNAUF Martin
Drug Innovation & Approval
-
SCHUMMER Dietmar
Drug Innovation & Approval
-
SEGETH Marian
Drug Innovation & Approval
-
WINK Joachim
Drug Innovation & Approval
-
SEIBERT Gerhard
Drug Innovation & Approval
-
Bronstrue Mark
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
HOFMANN Joachim
Intervet, Industriepark Hochst
-
SCHMIDT Frank
Aventis Pharma Deutschland GmbH, Process Development
-
VERTESY Laszli
Hoechst Marion Roussel Deutschland GmbH
-
MEIWES Johannes
Hoechst Marion Roussel Deutschland GmbH
-
SEIBERT Gerhard
Hoechst Marion Roussel Deutschland GmbH
-
Schmidt Frank
Aventis Pharma Deutschland Gmbh Process Development
-
Hofmann Joachim
Intervet Industriepark Hochst
-
RESTELLI Ermenegildo
Lepetit Research Center
-
SELVA Enrico
Marion Merrell Dow Research Institute, Lepetit Research Center
-
TAVECCHIA Paolo
Marion Merrell Dow Research Institute, Lepetit Research Center
-
COLOMBO Luigi
Marion Merrell Dow Research Institute, Lepetit Research Center
-
STELLA Sergio
Marion Merrell Dow Research Institute, Lepetit Research Center
-
RESTELLI Ermenegildo
Marion Merrell Dow Research Institute, Lepetit Research Center
-
RIPAMONTI Franca
Marion Merrell Dow Research Institute, Lepetit Research Center
-
MALABARBA Adriano
Marion Merrell Dow Research Institute, Lepetit Research Center
-
CIABATTI Romeo
Marion Merrell Dow Research Institute, Lepetit Research Center
-
SCOTTI Roberto
Marion Merrell Dow Research Institute, Lepetit Research Center
-
ANDREINI Bianca
Marion Merrell Dow Research Institute, Lepetit Research Center
-
CICILIATO ISMAELA
Vicuron Pharmaceuticals
-
SARUBBI EDOARDO
Aventis Pharma
-
STEFANELLI STEFANIA
IPIA G. Galilei
-
GASTALDO LUCIANO
Vicuron Pharmaceuticals
-
MONTANINI NICOLETTA
Vicuron Pharmaceuticals
-
LOSI DANIELE
Vicuron Pharmaceuticals
-
Colombo L
Bergamo大
-
EDER CLAUDIA
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
ISERT DIETER
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
LI ZIYU
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
PAULUS ERICH
Institut fur Mineralogie/Kristallographie der Johann Wolfgang Goethe-Universitat
-
VERTESY Laszlo
Natural Product Research
-
PAULUS Erich
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
HAMMANN Peter
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BECK Bernd
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BRONSTRUP Mark
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
MULLER Gunter
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
Broenstrup M
Aventis Pharma Deutschland Gmbh Frankfurt/main Deu
-
Sarubbi E.
Vicuron Pharmaceuticals S.r.l
-
Beck Bernd
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Gastaldo L
Vicuron Pharmaceuticals Italy S. R. L. Via R. Lepetit
-
Muller Gunter
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Scotti R
Marion Merrell Dow Research Institute Lepetit Research Center
-
Tavecchia P
Lepetit Res. Center Gerenzano(va) Ita
-
Andreini Bianca
Marion Merrell Dow Research Institute Lepetit Research Center
-
Ciciliato I
Vicuron Pharmaceuticals
-
Jordan Birgit
Drug Innovation & Approval
-
Marinelli Flavia
Dipartimento Di Biotecnologie E Scienze Molecolari Universita Dell' Insubria
-
Montanini N
Vicuron Pharmaceuticals
-
Li Ziyu
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Eder Claudia
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
著作論文
- Ala(0)-actagardine, a New Lantibiotic from Cultures of Actinoplanes liguriae ATCC 31048
- Feglymycin, a Novel Inhibitor of the Replication of the Human Immunodeficiency Virus Fermentation, Isolation and Structure Elucidation
- 3874 H1 and H3, Novel Antifungal Heptaene Antibiotics Produced by Streptomyces sp. HAG 003874
- Coniosetin, a Novel Tecramic Acid Antibiotic from Coniochaeta ellipsoidea DSM 13856
- Pluraflavins, Potent Antitumor Antibiotics from Saccharothrix sp. DSM 12931
- Cephaibols, New Peptaibol Antibiotics with Anthelmintic Properties from Acremonium tubakii DSM 12774
- Friulimicins: Novel lipopeptide Antibiotics with Peptidoglycan Synthesis Inhibiting Activity from Actinoplanes friuliensis sp. nov. : II. Isolation and Structural Characterization
- Components of the GE2270 Complex Produced by Planobispora rosea ATCC 53773
- New Semisynthetic Glycopeptides MDL 63, 246 and MDL 63, 042, and Other Amide Derivatives of Antibiotic A-40, 926 Active against Highly Glycopeptide-resistant VanA Enterococci
- Antibiotics GE23077, Novel Inhibitors of Bacterial RNA Polymerase : I. Taxonomy, Isolation and Characterization
- Ustilipids, Acylated β-D-Mannopyranosyl D-Erythritols from Ustilago maydis and Geotrichum candidum
- The Chemical Structure of Mumbaistatin, a Novel Glucose-6-phosphate Translocase Inhibitor Produced by Streptomyces sp. DSM 11641
- Cyclipostins, Novel Hormone-sensitive Lipase Inhibitors from Streptomyces sp. DSM 13381 II. Isolation, Structure Elucidation and Biological Properties